M. Plante, N. V. van Trommel, Mirte Schaafsma, A. Oza, Angela Rodriguez, Lisa Wang, K. Sikorska, S. Ferguson, K. Han, S. Lheureux, F. Amant
{"title":"2022-RA-678-ESGO CONTESSA/NEOCON-F试验:评估FIGO 2018期IB2宫颈癌新辅助化疗后保留生育能力手术的有效性和安全性","authors":"M. Plante, N. V. van Trommel, Mirte Schaafsma, A. Oza, Angela Rodriguez, Lisa Wang, K. Sikorska, S. Ferguson, K. Han, S. Lheureux, F. Amant","doi":"10.1136/ijgc-2022-esgo.45","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":114847,"journal":{"name":"Cervical cancer","volume":"2 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"2022-RA-678-ESGO CONTESSA/NEOCON-F trial: Assessing the effectiveness and safety of neoadjuvant chemotherapy followed by fertility-sparing surgery in FIGO 2018 stage IB2 cervical cancer\",\"authors\":\"M. Plante, N. V. van Trommel, Mirte Schaafsma, A. Oza, Angela Rodriguez, Lisa Wang, K. Sikorska, S. Ferguson, K. Han, S. Lheureux, F. Amant\",\"doi\":\"10.1136/ijgc-2022-esgo.45\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":114847,\"journal\":{\"name\":\"Cervical cancer\",\"volume\":\"2 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cervical cancer\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/ijgc-2022-esgo.45\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cervical cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ijgc-2022-esgo.45","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
2022-RA-678-ESGO CONTESSA/NEOCON-F trial: Assessing the effectiveness and safety of neoadjuvant chemotherapy followed by fertility-sparing surgery in FIGO 2018 stage IB2 cervical cancer